Co-Authors
This is a "connection" page, showing publications co-authored by NICOLA HANANIA and AMIR SHARAFKHANEH.
Connection Strength
3.494
-
COPD in the elderly patient. Semin Respir Crit Care Med. 2010 Oct; 31(5):596-606.
Score: 0.386
-
Budesonide/formoterol combination in COPD: a US perspective. Int J Chron Obstruct Pulmon Dis. 2010 Oct 05; 5:357-66.
Score: 0.385
-
Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis. 2010 May 06; 5:125-32.
Score: 0.375
-
The potential role of natural agents in treatment of airway inflammation. Ther Adv Respir Dis. 2007 Dec; 1(2):105-20.
Score: 0.317
-
Update on the pharmacologic therapy for chronic obstructive pulmonary disease. Clin Chest Med. 2007 Sep; 28(3):589-607, vi-vii.
Score: 0.311
-
Identification of sleep phenotypes in COPD using machine learning-based cluster analysis. Respir Med. 2024 Jun; 227:107641.
Score: 0.247
-
Elevated Risk of Chronic Respiratory Conditions within 60 Days of COVID-19 Hospitalization in Veterans. Healthcare (Basel). 2022 Feb 04; 10(2).
Score: 0.211
-
Obesity modulates diaphragm curvature in subjects with and without COPD. Am J Physiol Regul Integr Comp Physiol. 2017 Nov 01; 313(5):R620-R629.
Score: 0.156
-
The asthma COPD overlap syndrome (ACOS). Curr Allergy Asthma Rep. 2015 Mar; 15(3):509.
Score: 0.131
-
Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Ther Adv Chronic Dis. 2014 Sep; 5(5):212-27.
Score: 0.126
-
A simple rule to identify patients with chronic obstructive pulmonary disease who may need treatment reevaluation. Respir Med. 2014 Sep; 108(9):1310-20.
Score: 0.125
-
Perceptions and attitudes toward the use of nebulized therapy for COPD: patient and caregiver perspectives. COPD. 2013 Aug; 10(4):482-92.
Score: 0.115
-
Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res. 2011 Jan 11; 12:6.
Score: 0.098
-
Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011 Mar 01; 183(5):604-11.
Score: 0.096
-
Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc. 2008 May 01; 5(4):475-7.
Score: 0.081
-
The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma. Respir Med. 2007 May; 101(5):1007-14.
Score: 0.073
-
Beta-agonist intrinsic efficacy: measurement and clinical significance. Am J Respir Crit Care Med. 2002 May 15; 165(10):1353-8.
Score: 0.054
-
Smoking Status and Factors associated with COVID-19 In-Hospital Mortality among US Veterans. Nicotine Tob Res. 2022 03 26; 24(5):785-793.
Score: 0.053
-
Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review. Drug Saf. 2018 05; 41(5):489-509.
Score: 0.041
-
Persistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2016 07; 13(7):1016-25.
Score: 0.036
-
Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes. 2012 Aug 23; 10:100.
Score: 0.027
-
A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD. 2012 Apr; 9(2):151-9.
Score: 0.027
-
Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Prim Care Respir J. 2009 Sep; 18(3):198-207.
Score: 0.022